GMAB Competitors & Alternatives
Compare Genmab A/S ADS with similar stocks in the same industry
Pharmaceutical Preparations
GMAB
Main Stock$33.24
Tradestie Score
56
Market Cap
$19.56B
P/E Ratio
14.3
Revenue Growth
0.2%
Analyst Upside
+14.5%
Top Competitors
553 stocks in Pharmaceutical Preparations| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
LLY
Eli Lilly & Co.
|
$1054.32
|
$739.95B | 50.2 | 55 | Compare |
|
JNJ
Johnson & Johnson
|
$228.95
|
$448.07B | 20.6 | 63 | Compare |
|
ABBV
ABBVIE INC.
|
$225.43
|
$431.71B | 166.4 | 61 | Compare |
|
NVO
Novo-Nordisk A/S
|
$59.14
|
$262.92B | 15.6 | 50 | Compare |
|
AZN
AstraZeneca PLC
|
$192.12
|
$261.56B | 30.9 | 64 | Compare |
|
NVS
Novartis AG
|
$150.65
|
$254.99B | 20.5 | 67 | Compare |
|
ABT
Abbott Laboratories
|
$109.90
|
$232.30B | 28.5 | 59 | Compare |
|
MRK
Merck & Co., Inc.
|
$112.51
|
$225.13B | 14.3 | 60 | Compare |
|
PFE
Pfizer Inc.
|
$26.52
|
$154.70B | 15.2 | 69 | Compare |
|
SNY
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
|
$47.84
|
$121.27B | 19.3 | 57 | Compare |
More GMAB Analysis
Data updated: Feb 02, 2026 | Industry: Pharmaceutical Preparations (SIC 2834)
553 stocks in this industry